Andrew Abrams is a Partner at New Science Ventures, a venture capital firm focused on building companies that address large unmet needs in the Life Sciences and Information Technology sectors.
Prior to joining New Science Ventures, Andrew was an Associate in J.P. Morgan’s healthcare investment banking practice where he focused on mergers and acquisitions and debt and equity transactions in Europe and the U.S. He advised a wide array of clients spanning the biotechnology, pharmaceutical, medical device, diagnostic and healthcare service sub-sectors. He has also served as an analytical laboratory manager at Monsanto and as business development lead at an early-stage life science tools business, miniPCR bio.
Andrew received his B.A., M.A. and M.Sci. degrees in Natural Sciences and Biochemistry from the University of Cambridge where he was awarded the Richard Perham Scholarship for the most distinguished performance. He also participated in Cambridge’s year-long exchange program with the Massachusetts Institute of Technology. In addition, he holds an M.B.A. from Harvard Business School.
Prior to joining ProterixBio, Brett Masters served as VP of Engineering at Midé Technology Corporation, now a Hutchinson Company. Dr. Masters joined Midé in early 1997 and the role of VP of Engineering in 1998.
Dr. Masters’ educational background includes a Doctor of Science, a Master of Science, and a Bachelor of Science in Aeronautics and Astronautics from the Massachusetts Institute of Technology. Prior to this, Dr. Masters attended the University of Auckland in his homeland of New Zealand.
Dr. Masters has received several awards including the NASA OAST “Commendation for Technology Excellence” for the Middeck 0-Gravity Dynamics Experiment as well as the 1994 ASME Structures and Materials Award for work presented on “Global Structure Modeling Using Force-State Component Identification”. He also won the James Mean Memorial Award (MIT) for outstanding contribution in the design of a high-flying aircraft for sampling of ozone in the Antarctic Circle as well as the Luis de Florez Award (MIT) for design ingenuity in developing, building and testing a v-shaped hydrofoil for windsurfing.
Charlie is a seasoned financial professional with experience growing companies in fast-paced environments, improving financial performance of troubled enterprises and structuring complex transactions. His areas of expertise include design and implementation of accounting systems, budgets, forecasts and management reporting tools, capital fundraising, expense management and executing business plans to profitability.
Charlie was the Chief Financial Officer of The Merallis Company, a technology services firm located in Rocky Hill, CT, where he managed all aspects of accounting, finance and capital fundraising. Charlie defined financial reporting structures across this 90-member organization into 8 key functional departments to improve autonomy and fiscal efficiency. He revised the corporate financial plan and reduced projected expenses by 30% while maintaining expected revenue growth. Charlie also negotiated and managed all aspects of $9,500,000 in equity capital fund-raising to finance national sales and marketing initiatives.
Prior to Merallis, Charlie was a founding management member of PQC, Inc., a management services company that raised $50M in private capital, grew to 1,200 employees in 3 states and $80 million in revenue. As a Vice President at PQC, Charlie managed various aspects of finance and operations for the Company.
Charlie also founded Medical Claims Management (MCM), a practice reimbursement management and consulting firm focused on profitability improvement and operations management. MCM achieved profitability within the first 12 months of operations with $10M of revenues under management. Charlie curtailed his day-to-day involvement in this enterprise to join the founding management team of PQC and ultimately sold his interests in MCM.
Earlier in his career, Charlie worked as a Senior Consultant for Price Waterhouse and as Senior Accountant for Deloitte & Touche. He is a CPA, has a B.S. in Accountancy an A.S. in Management from Bentley College and an M.M. in Finance and Business Policy from the J.L. Kellogg School at Northwestern University.
Julio leads Operations and Assay Development at ProterixBio, applying his leadership experience in both Academic and Industrial laboratories, as well as his broad base of scientific expertise, which includes Cell and Molecular Biology, Biochemistry, Protein Chemistry and Biophysics.
Prior to joining ProterixBio in 2015, Julio was based at Cell Signaling Technology where he began as Department Head for Cytokine and Growth factor Development and Production, and Protein Expression, before heading the Department of Molecular Assay Development. Prior to that Julio was based at the Molecular Biology Department of R&D Systems.
Julio also has extensive academic experience having held the appointment of Assistant Professor and Adjunct Associate Professor in the Graduate Program at the Department of Biochemistry at the University of Minnesota.
Julio received his BS in Chemistry from the University of South Florida, Tampa, Fl. He received his MS and Ph.D. in Biochemistry from the University of Mississippi Medical Center, Jackson, MS. He received a post-doctoral training fellowship for studies at the National Cancer Institute, NIH, Bethesda, MD.